-
Je něco špatně v tomto záznamu ?
DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes
P. Heringová, J. Kašpárková, V. Brabec
Jazyk angličtina Země Německo
Typ dokumentu práce podpořená grantem
Grantová podpora
NR8562
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Medline Complete (EBSCOhost)
od 2003-01-01 do Před 1 rokem
- MeSH
- adukty DNA genetika metabolismus účinky léků MeSH
- biokatalýza MeSH
- cirkulární dichroismus MeSH
- cisplatina farmakologie chemie MeSH
- denaturace nukleových kyselin MeSH
- elektroforéza v polyakrylamidovém gelu MeSH
- G-kvadruplexy účinky léků MeSH
- lidé MeSH
- protinádorové látky farmakologie chemie MeSH
- sekvence nukleotidů MeSH
- spektrofotometrie ultrafialová MeSH
- techniky amplifikace nukleových kyselin MeSH
- telomerasa antagonisté a inhibitory metabolismus MeSH
- telomery genetika chemie MeSH
- tranzitní teplota MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
We studied the effect of antitumor cisplatin and inefficient transplatin on the structure and stability of G quadruplexes formed by the model human telomere sequence 5'-GGG(TTAGGG)(3)-3' using circular dichroism, UV-monitored thermal denaturation, and gel electrophoresis. In addition, to investigate whether there is a connection between the ability of cisplatin or transplatin to affect telomerase activity and stability of G quadruplexes, we also used a modified telomere repeat amplification protocol assay that uses an oligonucleotide substrate for telomerase elongation susceptible to forming a G quadruplex. The results indicate that cisplatin is more efficient than transplatin in disturbing the quadruplex structure, thereby precluding telomeric sequences from forming quadruplexes. On the other hand, the results of this work also demonstrate that in absence of free platinum complex, DNA adducts of antitumor cisplatin inhibit telomerase catalysis, so the mechanism underlying this inhibition does not involve formation of the G quadruplexes which are not elongated by telomerase.
Citace poskytuje Crossref.org
- 000
- 02948naa 2200481 a 4500
- 001
- bmc11022394
- 003
- CZ-PrNML
- 005
- 20140225104912.0
- 008
- 110729s2009 gw e Eng||
- 009
- AR
- 024 __
- $a 10.1007/s00775-009-0508-6 $2 doi
- 035 __
- $a (PubMed)19390878
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Heringová, Pavla. $7 _AN059902
- 245 10
- $a DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes / $c P. Heringová, J. Kašpárková, V. Brabec
- 314 __
- $a Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
- 520 9_
- $a We studied the effect of antitumor cisplatin and inefficient transplatin on the structure and stability of G quadruplexes formed by the model human telomere sequence 5'-GGG(TTAGGG)(3)-3' using circular dichroism, UV-monitored thermal denaturation, and gel electrophoresis. In addition, to investigate whether there is a connection between the ability of cisplatin or transplatin to affect telomerase activity and stability of G quadruplexes, we also used a modified telomere repeat amplification protocol assay that uses an oligonucleotide substrate for telomerase elongation susceptible to forming a G quadruplex. The results indicate that cisplatin is more efficient than transplatin in disturbing the quadruplex structure, thereby precluding telomeric sequences from forming quadruplexes. On the other hand, the results of this work also demonstrate that in absence of free platinum complex, DNA adducts of antitumor cisplatin inhibit telomerase catalysis, so the mechanism underlying this inhibition does not involve formation of the G quadruplexes which are not elongated by telomerase.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a protinádorové látky $x farmakologie $x chemie $7 D000970
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a biokatalýza $7 D055162
- 650 _2
- $a cirkulární dichroismus $7 D002942
- 650 _2
- $a cisplatina $x farmakologie $x chemie $7 D002945
- 650 _2
- $a adukty DNA $x genetika $x metabolismus $x účinky léků $7 D018736
- 650 _2
- $a elektroforéza v polyakrylamidovém gelu $7 D004591
- 650 _2
- $a G-kvadruplexy $x účinky léků $7 D054856
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a techniky amplifikace nukleových kyselin $7 D021141
- 650 _2
- $a denaturace nukleových kyselin $7 D009691
- 650 _2
- $a spektrofotometrie ultrafialová $7 D013056
- 650 _2
- $a telomerasa $x antagonisté a inhibitory $x metabolismus $7 D019098
- 650 _2
- $a telomery $x genetika $x chemie $7 D016615
- 650 _2
- $a tranzitní teplota $7 D044366
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kašpárková, Jana, $d 1969- $7 xx0068609
- 700 1_
- $a Brabec, Viktor, $d 1944- $7 jo20010087133
- 773 0_
- $t Journal of Biological Inorganic Chemistry $w MED00005752 $g Roč. 14, č. 6 (2009), s. 959-968
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110801153626 $b ABA008
- 991 __
- $a 20140225105724 $b ABA008
- 999 __
- $a ok $b bmc $g 881775 $s 732314
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00005752 $b 14 $c 6 $d 959-968 $m JBIC, Journal of biological inorganic chemistry $n J Biol Inorg Chem
- GRA __
- $a NR8562 $p MZ0
- LZP __
- $a 2011-4B09/jvme